Markt oder Branche auswählen:
| Unternehmen / Aktien | News 24 h | News 7 T | Kurs | ||
|---|---|---|---|---|---|
 | NOVO NORDISK | 18 | 40 | +0,03 % | |
| GENMAB | 4 | - | -0,45 % | |
| VESTAS WIND SYSTEMS | 2 | 9 | -2,77 % | |
| AP MOELLER-MAERSK | 1 | 23 | -0,08 % | |
| DANSKE BANK | 1 | 10 | -0,65 % | |
| DSV | 1 | 4 | +0,19 % | |
| AL SYDBANK | 1 | 2 | +0,07 % | |
| ZEALAND PHARMA | 1 | 1 | -0,51 % | |
| GN STORE NORD | 1 | - | 0,00 % | |
| ORSTED | - | 17 | +0,03 % |
- 24 h
- 7 Tage
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| Do | Zealand Pharma increases its share capital as a result of the exercise of employee warrants | 2 | GlobeNewswire (USA) | ||
| Do | FDA approves higher Wegovy dose via 4th priority voucher | 31 | pharmaphorum | ||
| Do | GN Store Nord A/S: Trading in GN Store Nord shares by board members, executives and associated persons | 3 | GlobeNewswire (USA) | ||
| Do | Novo uses FDA voucher to win speedy approval of higher-dose Wegovy | 7 | BioPharma Dive | ||
| Do | Novo's Wegovy HD passes muster under FDA national priority voucher program | 21 | FiercePharma | ||
| Do | Genmab ernennt neue Führungsspitze und vergibt aktienbasierte Vergütung | 2 | Investing.com Deutsch | ||
| Do | FDA approves new higher-dose version of Wegovy shots | 14 | BNN Bloomberg | ||
| Do | Genmab board appoints leadership, grants equity awards | 2 | Investing.com | ||
| Do | Constitution of the Board of Directors in Genmab A/S and Grant of Restricted Stock Units and Warrants to Employees in Genmab | 3 | GlobeNewswire (USA) | ||
| Do | Novo Nordisk Secures FDA Approval For Higher-Dose Wegovy | 22 | Benzinga.com | ||
| Do | AL Sydbank A/S: Annual General Meeting of AL Sydbank | 2 | GlobeNewswire (USA) | ||
| Do | Novo Nordisk wins U.S. approval for higher-dose Wegovy | 12 | Seeking Alpha | ||
| Do | Novo Nordisk mit Paukenschlag: Wegovy HD erhält US-Zulassung - Startschuss für die nächste ... | 556 | Der Aktionär | Darauf haben die Bullen gewartet: Der dänische Pharma-Gigant Novo Nordisk hat von der US-Gesundheitsbehörde FDA grünes Licht für Wegovy HD erhalten. Die Hochdosis-Variante der "Abnehmspritze" liefert... ► Artikel lesen | |
| Do | Novo Nordis erhält FDA-Zulassung für höher dosierte Wegovy-Injektion | 24 | Investing.com Deutsch | ||
| Do | Novo Nordisk wins FDA approval for higher-dose Wegovy injection | 14 | Investing.com | ||
| Do | Novo Nordisk A/S: Wegovy HD (semaglutide 7.2 mg) approved in the US, providing 20.7% mean weight loss | 462 | GlobeNewswire (Europe) | Wegovy HD demonstrated a mean weight loss of 20.7%1, and around one-third of patients achieved 25% or greater weight loss in the STEP UP trialFirst US FDA approval of a GLP-1 treatment under the Commissioner's... ► Artikel lesen | |
| Do | Eilmeldung am Abend: NOVO NORDISK A/S im kritischen Fokus! | 12 | Maximilian Berger | ||
| Do | SCHOCKMELDUNG - Novo Nordisk-Aktie stürzt ab, Insider verkaufen massiv | Hebelschein-Spekulant | |||
| Do | From containers to doorsteps: Maersk's push Into parcel logistics | 5 | FreightWaves | ||
| Do | Passing of Genmab A/S' Annual General Meeting | 348 | GlobeNewswire (Europe) | Company Announcement At Genmab A/S' Annual General Meeting held today March 19, 2026, the Annual Report for 2025 was approvedDischarge was given to the Board of Directors and the Executive Management... ► Artikel lesen |
1 2 3 4 5 Weiter >>
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und sowie Kurse und Daten von ARIVA.DE AG.